Stock listing
TSXV:AIML AI/ML Innovations Inc Stock
Follow AI/ML Innovations Inc into a list and get an email when it puts out news.
Delisted TSXV:AIML no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- TSXV:AIML
- Asset type
- Stock
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Nov 17, 2026
AI/ML Innovations Inc. Closes First Tranche of Private Placement
Latest news
AI/ML Innovations Inc on 6ix
- News releases
- 39 in the last 12 months · 102 in all · newest Nov 17, 2026 · oldest 2007
- Decks
- 3 decks · latest Feb 14, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2024) | Investor deck | 24 slides | Feb 14, 2024 |
| Investor Presentation (March 2023) | Investor deck | 26 slides | March 2023 |
| Investor Presentation (November 2021) | Investor deck | 27 slides | November 2021 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of units Tranche closed: C$500,000 raised · C$0.05 a unit · 1 warrant at C$0.15 for 60 months · free to trade Mar 18, 2027 Use of proceeds: General working capital | Nov 17, 2026 | US$349,871 |
| Private placement of units Closed: C$365,000 in the latest tranche · C$0.05 a unit · 1 warrant at C$0.15 for 60 months · free to trade Jan 15, 2027 | Sep 14, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Cap table
Built by 6ix from AI/ML Innovations Inc’s releases · as of Nov 17, 2026
- Fully diluted
- 17,580,000
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Warrants | 17,580,000 | Nov 17, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · C$0.15 · expire about Nov 2031 |
| Warrants · C$0.15 · expire about Aug 2031 |
| Broker warrants · C$0.15 · expiry not stated |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alan Rabinowitz Other companies: AIML Innovations Inc (Chief Medical Officer · Since at least Jan 27, 2025) | Chief Medical Officer and Director of Medical Partnerships · Since Jan 27, 2025 · Appointed, no departure found |
| Erik Suokas Other companies: AIML Innovations Inc (COO, AIML & Neural Cloud · Since at least Jan 7, 2026) | Chief Operating Officer · Since Jan 7, 2026 · Appointed, no departure found |
| Kendra Low Other companies: AIML Innovations Inc (Corporate Secretary · Dec 3, 2024 – Nov 4, 2026 · Past) | Corporate Secretary · Since Dec 3, 2024 · Appointed, no departure found |
| Lynn Chapman Other companies: AIML Innovations Inc (CFO, AIML · Since Oct 1, 2026) | Chief Financial Officer · Since Oct 1, 2026 · Appointed, no departure found |
| Mehmet A. Kosoglu Other companies: AIML Innovations Inc (Head of Regulatory for NeuralCloud Solutions Inc. · Since at least Sep 1, 2026) | Head of Regulatory · Since Sep 1, 2026 · Appointed, no departure found |
| Paul Dorian Other companies: AIML Innovations Inc (Medical Innovation Architect and Head of the Medical Advisory Board · Since at least Jan 28, 2026) | Medical Innovation Architect and Head of the Medical Advisory Board · Since Jan 28, 2026 · Appointed, no departure found |
| Peter Kendall Other companies: AIML Innovations Inc (President and Chief Commercialization Officer · Jan 6, 2025 – Nov 4, 2026 · Past) | President and Chief Commercialization Officer · Since Jan 6, 2025 · Appointed, no departure found |
| Terence Lee Other companies: AIML Innovations Inc (Chief Financial Officer · Dec 3, 2024 – Nov 4, 2026 · Past) | Chief Financial Officer · Dec 3, 2024 – Oct 2, 2026 · Past |
| Drew Dundas | Chair · Since May 22, 2025 · Appointed, no departure found |
| Medical Innovation Architect | Officer · Since May 11, 2026 · Appointed, no departure found |
All 11 people
| Person | Seat |
|---|---|
| Randy Duguay | Director · Until Oct 11, 2024 · Past |
Log in to ask 6ix AI your own questions about AI/ML Innovations Inc.